US regulators unveil plan to transform FDA to global agency
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has unveiled a ten-year strategy for transforming itself from a domestic agency working in an international world into a global agency capable of addressing product issues that arise around the world.